A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632, a strain with the ability to degrade purines

  1. Rodríguez, J.M.
  2. Garranzo, M.
  3. Segura, J.
  4. Orgaz, B.
  5. Arroyo, R.
  6. Alba, C.
  7. Beltrán, D.
  8. Fernández, L.
Journal:
Frontiers in Microbiology

ISSN: 1664-302X

Year of publication: 2023

Volume: 14

Type: Article

DOI: 10.3389/FMICB.2023.1111652 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus